MENU
MHIP
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

MHIP stock forecast, quote, news & analysis

The investment seeks to generate returns (before Fund fees and expenses) that over time exceed the healthcare costs for an individual utilizing an employer-provided health plan in the United States (“U... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for MHIP with price predictions
Nov 03, 2026

MHIP in downward trend: price may drop because broke its higher Bollinger Band on October 15, 2026

MHIP broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 2 similar instances where the stock broke above the upper band. In 1 of the 2 cases the stock fell afterwards. This puts the odds of success at 50%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for MHIP just turned positive on October 12, 2026. Looking at past instances where MHIP's MACD turned positive, the stock continued to rise in 3 of 3 cases over the following month. The odds of a continued upward trend are 90%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks to generate returns (before Fund fees and expenses) that over time exceed the healthcare costs for an individual utilizing an employer-provided health plan in the United States (“U.S. Healthcare Cost Inflation”). The common stocks in which the fund primarily invests are those issued by companies in the U.S. healthcare sector and sectors that comprise the supply chain for the U.S. healthcare sector, and include companies of all capitalization sizes. Milliman determines the common stock portfolio weight by implementing a factor approach. The fund is non-diversified.

Market Cap

The average market capitalization across the Milliman Healthcare Inflation Plus ETF (MHIP) ETF is 130.54B. The market cap for tickers in the group ranges from 8.56B to 1.26T. LLY holds the highest valuation in this group at 1.26T. The lowest valued company is CORT at 8.56B.

High and low price notable news

The average weekly price growth across all stocks in the Milliman Healthcare Inflation Plus ETF (MHIP) ETF was 0%. For the same ETF, the average monthly price growth was 4%, and the average quarterly price growth was 8%. MDLN experienced the highest price growth at 25%, while ALNY experienced the biggest fall at -31%.

Volume

The average weekly volume growth across all stocks in the Milliman Healthcare Inflation Plus ETF (MHIP) ETF was 27%. For the same stocks of the ETF, the average monthly volume growth was 3% and the average quarterly volume growth was -30%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 48
Price Growth Rating: 31
SMR Rating: 62
Profit Risk Rating: 61
Seasonality Score: 22 (-100 ... +100)